Valsartan, Hydrochlorothiazide

3 trials 1 recruiting CCardiology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

3 Sponsors

12 Countries

Phase II

Phase III/IV

Phase IV

Phase II: 1 Phase III/IV: 1 Phase IV: 1

Oversight events:

9 temporary halts 1 urgent safety measure across 1 trial

View oversight register →

Sponsors using this IMP

Andrea Di Marco 1 Medical University Of Vienna 1 Novartis Pharma AG 1

All trials

3 total

Prevention of heart disease in heart-healthy patients with diabetes based on a special parameter (NT-proBNP) Pending

2024-519051-28-01 Phase IV 2 countries Medical University Of Vienna
Withdrawal of neurohormonal therapy in patients with non-ischemic cardiomyopathy, no late gadolinium enhancement, and negative genetic testi… Recruiting

2025-521780-12-00 Phase III/IV 1 country Andrea Di Marco
A proof of concept and dose-finding study of XXB750 in patients with heart failure Ended

2023-504678-39-00 Phase II 11 countries Novartis Pharma AG

Showing 1–3 of 3 trials

← All drugs A–Z